Cardiac resynchronisation therapy for severe heart failure
Medical Services Advisory Committee
Record ID 32006000746
English
Authors' objectives:
The aim of this report is to systematically review the literature on treatment of heart failure by permanent cardiac resynchronisation therapy (CRT).
Authors' recommendations:
On the strength of evidence pertaining to safety, effectiveness and cost-effectiveness, MSAC recommends that public funding should be supported for the use of cardiac resynchronisation therapy in patients who have moderate to severe chronic heart failure (NYHA class III or IV) despite optimised medical therapy and who meet all of the following criteria-sinus rhythm, a left ventricular ejection fraction of less than or equal to 35% and a quasi-random signal (QRS) duration greater than or equal to 120ms.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.msac.gov.au/
Year Published:
2006
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Costs and Cost Analysis
- Cardiac Pacing, Artificial
- Heart Failure
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.